IM CANNABIS CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.78 CAD | +4.00% |
|
-7.14% | +69.57% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 49.55 | 399 | 287.7 | 9.84 | 6.161 | 10.45 |
| Enterprise Value (EV) 1 | 49.55 | 399 | 287.7 | 9.84 | 6.161 | 10.45 |
| P/E ratio | - | - | - | - | - | - |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 5.46 x | 25.1 x | 5.3 x | 0.18 x | 0.13 x | 0.23 x |
| EV / Revenue | 5.46 x | 25.1 x | 5.3 x | 0.18 x | 0.13 x | 0.23 x |
| EV / EBITDA | -27.3 x | -71.3 x | -13.1 x | -0.86 x | -0.77 x | -2.49 x |
| EV / FCF | - | - | -7,387,347 x | -692,887 x | - | - |
| FCF Yield | - | - | -0% | -0% | - | - |
| Price to Book | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 3,644 | 3,974 | 6,818 | 7,570 | 13,394 | 13,394 |
| Reference price 2 | 13.60 | 100.4 | 42.20 | 1.300 | 0.4600 | 0.7800 |
| Announcement Date | 20/04/20 | 23/04/21 | 31/03/22 | 29/03/23 | 28/03/24 | - |
1CAD in Million2
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Net sales 1 | 9.074 | 15.89 | 54.3 | 54.34 | 48.8 | 46.3 |
| EBITDA 1 | -1.814 | -5.592 | -22.03 | -11.49 | -7.97 | -4.2 |
| EBIT 1 | - | - | -38.39 | -30.79 | -12.79 | -10.3 |
| Operating Margin | - | - | -70.7% | -56.67% | -26.21% | -22.25% |
| Earnings before Tax (EBT) 1 | - | - | -18.01 | -26.06 | -9.457 | -10.3 |
| Net income 1 | - | - | -18.52 | -188.9 | -9.498 | -10.3 |
| Net margin | - | - | -34.1% | -347.64% | -19.46% | -22.25% |
| EPS | - | - | - | - | - | - |
| Free Cash Flow | - | - | -38.95 | -14.2 | - | - |
| FCF margin | - | - | -71.73% | -26.14% | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 20/04/20 | 23/04/21 | 31/03/22 | 29/03/23 | 28/03/24 | - |
1CAD in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 14.39 | 20.03 | 23.57 | 23.82 | 14.17 | 14.46 | 13.17 | 13.21 | 12.37 | 10.7 | 10.6 | 10.9 | 11.9 | 13 |
| EBITDA 1 | -7.008 | -8.278 | -4.504 | -4.624 | -3.666 | -1.884 | -1.284 | -0.499 | -1.293 | -4.251 | -1.3 | -1.2 | -1 | -0.7 |
| EBIT 1 | -14.24 | -11.72 | -11.55 | -11.64 | -5.526 | -10.71 | 2.973 | -1.752 | -2.259 | -5.165 | -2.9 | -2.7 | -2.5 | -2.2 |
| Operating Margin | -98.97% | -58.53% | -49% | -48.89% | -39% | -74.05% | 22.57% | -13.27% | -18.26% | -48.28% | -27.36% | -24.77% | -21.01% | -16.92% |
| Earnings before Tax (EBT) 1 | -6.021 | -12.16 | -10.99 | -20.16 | -4.328 | -9.76 | 0.028 | -3.866 | -2.011 | -2.699 | -2.9 | -2.7 | -2.5 | -2.2 |
| Net income 1 | -4.285 | -12.49 | -9.452 | -18.98 | -127.8 | -33.03 | 0.309 | -3.459 | -2.15 | -3.289 | -2.9 | -2.7 | -2.5 | -2.2 |
| Net margin | -29.77% | -62.35% | -40.1% | -79.67% | -901.82% | -228.39% | 2.35% | -26.19% | -17.38% | -30.74% | -27.36% | -24.77% | -21.01% | -16.92% |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 15/11/21 | 31/03/22 | 12/05/22 | 15/08/22 | 14/11/22 | 29/03/23 | 15/05/23 | 14/08/23 | 13/11/23 | 28/03/24 | - | - | - | - |
1CAD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow | - | - | -39 | -14.2 | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex | - | 2.62 | 4.58 | - | - | - |
| Capex / Sales | - | 16.49% | 8.43% | - | - | - |
| Announcement Date | 20/04/20 | 23/04/21 | 31/03/22 | 29/03/23 | 28/03/24 | - |
1CAD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.78
CAD
Average target price
3.45
CAD
Spread / Average Target
+342.31%
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +69.57% | 7.63M | |
| +23.05% | 3.66B | |
| +109.78% | 2B | |
| +87.30% | 61.69M |
- Stock Market
- Equities
- IMCC Stock
- Financials IM Cannabis Corp.
